Peta revolusi penyuntingan gen
CRISPR Decoded
Jelajahi teknologi, pengobatan, penyakit, ilmuwan, perusahaan, uji klinis, dan penemuan yang membentuk masa depan kedokteran genetik.
Mulai dari posisimu saat ini
Situs ini ditulis untuk pembaca yang sangat beragam sekaligus. Setiap pintu di bawah ini mengarah ke database yang sama dari sudut yang berbeda. Tidak ada yang disederhanakan berlebihan, dan tidak ada yang mengasumsikan kamu memiliki gelar biologi.
New to all of thisMulai dari apa itu DNA dan kembangkan dari sana. Tidak perlu latar belakang apa pun.
A patient or familyApa yang sudah disetujui, apa yang masih dalam uji klinis, dan cara membedakannya.
Mengikuti perkembangan industriSiapa yang mengembangkan apa, pada tahap mana. Informasi, bukan saran medis.
Untuk bidang pangan dan pertanianTanaman dan hewan ternak hasil pengeditan gen, serta alasan mengapa aturannya berbeda di tiap negara.
Jelajahi pengeditan gen
Tujuh cara ilmuwan mengubah materi genetik. Setiap halaman dibuka dengan penjelasan dalam bahasa sederhana, lalu bisa sedetail yang kamu inginkan.
CRISPR-Cas9A protein that can be programmed with a short RNA guide to find one specific sequence in a genome and cut it.
Hiroshi Nishimasu, F. Ann Ran,... · CC BY-SA 3.0
Base EditingChemically converts one DNA letter into another at a chosen position, without cutting both strands of the double helix.
Prime EditingWrites a new stretch of DNA sequence directly into a chosen site, using a guide that carries the replacement text with it.
CRISPR-Cas12A family of CRISPR nucleases that cut DNA leaving staggered ends, use a different sequence requirement from Cas9, and can be smaller.
CRISPR-Cas13Targets RNA rather than DNA, so it can silence a gene's message without touching the genome itself.
Cas14 and miniature Cas systemsUnusually small CRISPR nucleases, roughly a third the size of Cas9, discovered in archaea and bacteriophages.
RNA EditingChanges letters in the RNA message rather than in the DNA, so the effect is real but temporary and the genome is untouched.
Bandingkan secara berdampinganPresisi, pemotongan, ukuran muatan, pengiriman, kematangan, risiko
Penyakit yang menjadi target
Setiap halaman penyakit menyatakan dengan jelas apakah pengeditan gen merupakan pengobatan yang sudah disetujui, sedang dalam uji klinis, atau masih sebatas ide di laboratorium.
Sickle Cell DiseaseBlood disorders
SpicyMilkBoy · CC BY-SA 4.0
Beta ThalassemiaBlood disorders
Dr Graham Beards · CC BY-SA 4.0
ATTR AmyloidosisMetabolic disease
Hereditary AngioedemaRare genetic disease
LucyHAE · CC BY-SA 3.0
High Cholesterol and Familial HypercholesterolemiaCardiovascular disease
CancerCancer
Mikael Häggström, M.D. Author info... · CC0
Leukemia and LymphomaCancer
https://wellcomeimages.org/indexplu... · CC BY 4.0
HIVInfectious disease
Photo Credit: C. Goldsmith
Content... · Public domain
Duchenne Muscular DystrophyMuscular disease
Dr. Edwin P. Ewing, Jr. · Public domain
Cystic FibrosisRare genetic disease
Perawatan
Obat-obatan dengan nama, disertai status regulasi di setiap rekaman.
Obat yang disetujui di CRISPR Decoded: Casgevy (exagamglogene autotemcel) · Lyfgenia (lovotibeglogene autotemcel) · Zynteglo (betibeglogene autotemcel)
Uji klinis
Di mana bukti sebenarnya dibuat.
Perusahaan yang perlu diketahui
Siapa yang membangun apa, dan sejauh mana setiap program berjalan.
Ilmuwan yang mengubah bidang ini
Apa yang sebenarnya dikontribusikan setiap orang, atribusi di bidang ini masih diperdebatkan, dan kami menyebutkan di mana.
Jennifer DoudnaStructural biochemist who, with Emmanuelle Charpentier, showed that Cas9 could be programmed with a single guide RNA to cut chosen DNA, and shared the 2020 Nobel Prize in Chemistry for it.
Christopher Michel · CC BY-SA 4.0
Emmanuelle CharpentierMicrobiologist who discovered tracrRNA, the missing component of the CRISPR-Cas9 system, and shared the 2020 Nobel Prize in Chemistry with Jennifer Doudna.
Bianca Fioretti, Hallbauer & Fioretti · CC BY-SA 4.0
Feng ZhangBioengineer who led one of the first demonstrations of CRISPR genome editing in human cells and discovered several new CRISPR systems including Cas12a and Cas13.
PuppyEggs · CC BY-SA 4.0
David LiuChemical biologist whose laboratory invented base editing and prime editing, the two techniques that changed gene editing from cutting to writing.
ServiceAT · CC BY-SA 4.0
George ChurchGeneticist whose laboratory independently demonstrated CRISPR editing in human cells in 2013, and a founder of an unusually large number of genomics companies.
Christopher Michel · CC BY-SA 4.0
Virginijus ŠikšnysLithuanian biochemist who independently showed that Cas9 could be programmed to cut DNA, publishing in 2012, and whose contribution is often omitted from popular accounts.
Gie2016 · CC BY-SA 4.0
Berita gene editing terbaru
Artikel nyata dari penerbit bernama. Setiap judul berita menautkan ke sumber aslinya, kami tidak pernah menulis ulang atau menerbitkan kembali.
Rice plants can fight off devastating disease after gene editing with AI-designed tool
University of Missouri researchers have created rice plants that resist bacterial blight, a devastating disease that threatens one of the world's most…
STAT+: After two deaths in autoimmune cell therapy trial, Artiva is shutting down
Recent deaths are setbacks in drug companies’ interest in applying cancer therapy strategies to autoimmune diseases.
Bonjour Genomics: A Video from ASHG
GEN editors Uduak Thomas and Julianna LeMieux, PhD, recap ASHG, highlighting key sessions, Ultima Genomics’ user group meeting, Illumina news, and…
Artiva to wind down after two patient deaths in autoimmune cell therapy trials
Cell therapy biotech Artiva Biotherapeutics abruptly announced Tuesday morning that it is effectively shutting down and laying off almost all of its staff…
Outpace ends an ovarian cancer trial; Incyte data impresses at ESMO
Plus news about Genmab, Rumi, Prana and Fractyl. Outpace Bio ends cell therapy trial: The Seattle startup canned a Phase 1 ovarian cancer trial of its…
STAT+: Nonprofit resurrects shelved gene therapy after startup shuts down
Last year, U.K. gene therapy startup Bloomsbury Genetic Therapies announced it was shutting down after dosing just one patient. Now, a nonprofit is…
Spatial Proteomics for Precision Oncology
In this GEN webinar, Bernd Bodenmiller, PhD (University of Zürich), illustrates this integrated approach through two recent examples. The post Spatial…
CRISPR dijelaskan
Mulai dari awal sekali. Tidak perlu latar belakang biologi.